{"id":3690,"date":"2023-01-27T14:55:22","date_gmt":"2023-01-27T13:55:22","guid":{"rendered":"https:\/\/ibtherapeutics.com\/sv\/mfn_news\/infant-bacterial-therapeutics-publicerar-arsredovisning-for-2021-i-xhtml-format\/"},"modified":"2023-10-02T13:51:37","modified_gmt":"2023-10-02T11:51:37","slug":"infant-bacterial-therapeutics-publicerar-arsredovisning-for-2021-i-xhtml-format","status":"publish","type":"mfn_news","link":"https:\/\/ibtherapeutics.com\/sv\/pressmeddelanden\/infant-bacterial-therapeutics-publicerar-arsredovisning-for-2021-i-xhtml-format\/","title":{"rendered":"Infant Bacterial Therapeutics publicerar \u00c5rsredovisning f\u00f6r 2021 i XHTML format"},"content":{"rendered":"<div>\n<p>Den 31 mars 2022 publicerade IBT sin \u00e5rsredovsning f\u00f6r 2021. Filformatet som d\u00e5 anv\u00e4ndes var PDF. Idag publicerar IBT samma rapport i XHTML format. Inneh\u00e5llet i rapporten har inte \u00e4ndrats.<\/p>\n<p>se l\u00e4nk<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FF1hRv9MGJGxJeFUZiUuh6x9Epzm8hwrMJXZbJaIY3MmWVf72wBNDweRgaI0c1ThszwYhULYLU4AmP7c9HByLKfo4vlu6bwF5ApXowi3j0cEAL7VumSLPBJB8nyZxlZnvAryJAXbs6Me84V1M_6EDIz4e8eemtWXcC4fSteuGif2mKgLcDeqSCRQY2qw4h2Mc2hH4NdByzQQZkTDCSG_Og==\" target=\"_blank\" title=\"\" rel=\"nofollow noopener\">https:\/\/ibtherapeutics.com\/sv\/investerare\/financial-rapporter\/<\/a><\/p>\n<p><\/p>\n<p><strong>F\u00f6r mer information kontakta<\/strong><\/p>\n<p>Staffan Stro\u0308mberg, VD<\/p>\n<p>Maria Ekdahl, CFO<\/p>\n<p>                    <\/p>\n<div id=\"quote-carousel-viewer\"><\/div>\n<\/p><\/div>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/4fef29bb-73b1-4f57-91e3-aa92798fdf30\" target=\"_blank\" rel=\"nofollow noopener\">A\u030arsredovisning 2021<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy?url=https%3A%2F%2Fml-eu.globenewswire.com%2FResource%2FDownload%2F4fef29bb-73b1-4f57-91e3-aa92798fdf30\"><span class=\"mfn-attachment-icon\"><span class=\"dash dashicons dashicons-media-default\"><\/span><\/span>A\u030arsredovisning 2021<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Den 31 mars 2022 publicerade IBT sin \u00e5rsredovsning f\u00f6r 2021. Filformatet som d\u00e5 anv\u00e4ndes var PDF. Idag publicerar IBT samma rapport i XHTML format. Inneh\u00e5llet i rapporten har inte \u00e4ndrats. se l\u00e4nkhttps:\/\/ibtherapeutics.com\/sv\/investerare\/financial-rapporter\/ F\u00f6r mer information kontakta Staffan Stro\u0308mberg, VD Maria Ekdahl, CFO Bifogade filer A\u030arsredovisning 2021 A\u030arsredovisning 2021<\/p>\n","protected":false},"template":"","_links":{"self":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3690"}],"collection":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/media?parent=3690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}